WO2024231843 - TRETINOIN LIPOSOME FORMULATIONS AND USES THEREOF TO TREAT CANCER
National phase entry is expected:
Publication Number
WO/2024/231843
Publication Date
14.11.2024
International Application No.
PCT/IB2024/054455
International Filing Date
07.05.2024
Title **
[English]
TRETINOIN LIPOSOME FORMULATIONS AND USES THEREOF TO TREAT CANCER
[French]
FORMULATIONS DE LIPOSOMES DE TRÉTINOÏNE ET LEURS UTILISATIONS POUR TRAITER LE CANCER
Applicants **
HIGHFIELD BIOPHARMACEUTICALS CORPORATION
202, Building 2
Minsheng Pharmaceutical Industrial Park, No. 658,
Bin’an Road
Binjiang District, Hangzhou, Zhejiang, CN
Inventors
XU, Yuhong
Room 303, Unit 1, No. 304
Wulin Road
Hangzhou, Zhejiang, CN
ZHENG, Anjie
No. 2, Daijiaqiangmen, Xixing Street, Xixing Street
Binjiang District, Hangzhou, Zhejiang, CN
DAI, Yongchao
Binhe Garden
Binjiang District, Hangzhou, Zhejiang, CN
LIU, Jianmin
Building 3, Hengfu Homestead, Lane 99, Hechi Road
Pudong New Area, Shanghai 1102, CN
JIN, Shanshan
2101, Building 11, Jinpan Yunting Mansion, Donghu Street
Linping District, Hangzhou, Zhejiang, CN
XU, Fengwei
Yinlan Mansion, Shushan Street
Xiaoshan District, Hangzhou, Zhejiang, CN
WU, Xuan
Unit 5, Building 17, Lanqiao Mingyuan
Shangcheng District, Hangzhou, Zhejiang 502, CN
WANG, Xun
Unit 401, Building 7, Chunbo Xiyuan
Binjiang District, Hangzhou, Zhejiang, CN
GUO, Wenjun
26, Xiangyun Yayuan, Xixing Street
Binjiang District, Hangzhou, Zhejiang, CN
HUANG, Yongfeng
Room 502, No. 39, Lane 288, Chengfeng Road
Chuansha New Town, Pudong New Area, Shanghai, CN
Priority Data
202310535456.7
09.05.2023
CN
202310679399.X
08.06.2023
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1573 | |
| EPO | Filing, Examination | 9976 | |
| Japan | Filing | 530 | |
| South Korea | Filing | 608 | |
| USA | Filing, Examination | 4835 |
Total: 17522 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Described are methods for treating cancer an effective amount of all-trans retinoic acid (ATRA) disposed in a liposome.[French]
Sont décrites des méthodes de traitement du cancer, une quantité efficace d'acide tout-trans rétinoïque (ATRA) étant présente dans un liposome.